PARP Inhibitors in Prostate Cancer–the Preclinical Rationale and Current Clinical Development

by Verneri Virtanen, Kreetta Paunu, Johanna K. Ahlskog, Reka Varnai, Csilla Sipeky, Maria Sundvall
Published 2019-07-01

More Than Meets the Eye: Scientific Rationale behind Molecular Imaging and Therapeutic Targeting of Prostate-Specific Membrane Antigen (PSMA) in Metastatic Prostate Cancer and Beyo...

by Anniina Hyväkkä, Verneri Virtanen, Jukka Kemppainen, Tove J. Grönroos, Heikki Minn, Maria Sundvall
Published 2021-05-01